BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11135319)

  • 21. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.
    Klomp HJ; Zernial O; Flachmann S; Wellstein A; Juhl H
    Clin Cancer Res; 2002 Mar; 8(3):823-7. PubMed ID: 11895915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells.
    Wan M; Huang J; Jhala NC; Tytler EM; Yang L; Vickers SM; Tang Y; Lu C; Wang N; Cao X
    Am J Pathol; 2005 May; 166(5):1379-92. PubMed ID: 15855639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells.
    De Boer WI; Houtsmuller AB; Izadifar V; Muscatelli-Groux B; Van der Kwast TH; Chopin DK
    Int J Cancer; 1997 Apr; 71(2):284-91. PubMed ID: 9139855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
    Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
    Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
    Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson SA; Johnson GR; Korc M
    Int J Cancer; 1997 Jul; 72(3):512-7. PubMed ID: 9247297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction and expression of cyclin D3 in human pancreatic cancer.
    Ebert MP; Hernberg S; Fei G; Sokolowski A; Schulz HU; Lippert H; Malfertheiner P
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):449-54. PubMed ID: 11469683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
    Chen PH; Yang CR
    J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internalization of growth factor-receptor complexes under the influence of antibodies initiates cell apoptosis in vitro.
    Lavrovsky VA; Chagin AS; Subkhankulova TN
    Eur J Cell Biol; 1999 Mar; 78(3):194-8. PubMed ID: 10219569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.
    Stoeltzing O; Liu W; Reinmuth N; Fan F; Parikh AA; Bucana CD; Evans DB; Semenza GL; Ellis LM
    Am J Pathol; 2003 Sep; 163(3):1001-11. PubMed ID: 12937141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
    Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
    Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
    Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironmental factors and extracellular matrix degradation in pancreatic cancer.
    Binker MG; Binker-Cosen MJ; Binker-Cosen AA; Cosen-Binker LI
    JOP; 2014 Jul; 15(4):280-5. PubMed ID: 25076320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
    Kleeff J; Ishiwata T; Kumbasar A; Friess H; Büchler MW; Lander AD; Korc M
    J Clin Invest; 1998 Nov; 102(9):1662-73. PubMed ID: 9802880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
    von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S
    Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.
    Löhr M; Schmidt C; Ringel J; Kluth M; Müller P; Nizze H; Jesnowski R
    Cancer Res; 2001 Jan; 61(2):550-5. PubMed ID: 11212248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
    Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
    Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.